AbbVie Inc (LTS:0QCV)
$ 174.92 -0.4 (-0.23%) Market Cap: 302.34 Bil Enterprise Value: 366.13 Bil PE Ratio: 60.57 PB Ratio: 51.09 GF Score: 86/100

Q4 2018 AbbVie Inc Earnings Call Transcript

Jan 25, 2019 / 02:00PM GMT
Release Date Price: $70.24 (-9.44%)
Operator

Good morning, and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2018 Earnings Conference Call. (Operator Instructions)

And I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations.

Elizabeth Shea
AbbVie Inc. - VP of IR

Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Vice Chairman and President; Bill Chase, Executive Vice President of Finance and Administration; and Rob Michael, Senior Vice President and Chief Financial Officer.

Before we get started, I would like to remind you that some statements we make today are or may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Additional information about the factors that may affect AbbVie

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot